with increased graft loss in the recipients of their kidneys. Our goal was to investigate if this relationship was reflected at an earlier stage postdonation, possibly early enough for recipient risk prediction based on donor response to nephrectomy. Using national registry data, we studied 29 464 recipients and their donors from [2008][2009][2010][2011][2012][2013][2014][2015][2016] to determine the association between donor 6-month postnephrectomy estimated GFR (eGFR) and recipient death-censored graft failure (DCGF). We explored donor BMI as an effect modifier, given the association between obesity and hyperfiltration. 
| INTRODUC TI ON
In considering recipient outcomes following living donor kidney transplantation (LDKT), predonation donor risk factors of lower estimated GFR (eGFR), older age, and higher BMI have been associated with greater risk of recipient graft loss. [1] [2] [3] [4] Postdonation, development of end-stage renal disease (ESRD) in the donor is associated with increased risk of graft loss in the recipient. 5 Although this is interesting biologically, it is of less utility for clinical risk prediction because ESRD is a rare postdonation event that generally occurs many years after donation. [6] [7] [8] More useful might be an earlier donor physiologic response to nephrectomy and its relation to recipient outcomes.
Given that most living donors experience a gradual increase in eGFR following donation as their remaining kidney hypertrophies, [9] [10] [11] [12] lower donor eGFR at an early interval after donor nephrectomy might serve as an earlier or more subtle predictor of recipient graft loss compared to waiting for ESRD development. 13, 14 This must be considered in the context that postdonation eGFR is related not only to intrinsic kidney quality (and hence would also reflect the kidney that was donated), but also to the ability of the remaining kidney to hypertrophy. 15 As such, donor obesity must also be investigated as an effect modifier:
obese donors are more likely to have already developed obesity-related glomerulomegaly, 16 so their donor kidneys might have less physiologic reserve and less ability to hypertrophy in response to donation. Thus, higher postnephrectomy eGFR in obese donors might indicate hyperfiltration rather than physiologic recovery and portend a different risk prediction for recipients than the same finding in nonobese donors.
To examine if donor postnephrectomy eGFR can function as a predictor of recipient outcomes, we used national registry data to examine the association between 6-month postdonation eGFR and LDKT recipient graft loss. In addition, we investigated whether this association varied by donor BMI.
| ME THODS

| Data source
This study used data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donor, wait-listed candidates, and transplant recipients in the United
States, submitted by the members of the Organ Procurement and Transplantation Network (OPTN), and has been described elsewhere. 17 The Health Resources and Services Administration (HRSA), US Department of Health and Human Services, provides an oversight to the activities of the OPTN and SRTR contractors.
| Study population and ascertainment of the exposure
We studied 42 053 kidney-only adult LDKT recipients and their donors between 1/1/2008 and 12/31/2016. Donor 6-month postnephrectomy eGFR was calculated from 6-month OPTN donor follow-up forms using the CKD-EPI equation. 18 We considered any eGFR reported between 3 and 9 months postdonation to be a 6-month postdonation eGFR.
| LDKT recipient outcomes
We examined all-cause graft failure (ACGF) and death-censored graft failure (DCGF), defined as resumption of maintenance dialy- To select the model with the best fit, we compared 3 models all adjusted for the above covariates with the outcome of ACGF-one including predonation eGFR, one including postdonation eGFR, and one including both predonation and postdonation eGFR-using the Akaike information criterion (AIC) as an estimator of relative quality of models. The model with the best fit, selected by the lowest AIC, included only postdonation eGFR, meaning that postdonation eGFR provided more information than predonation eGFR. We used the same set of covariates for the outcome of DCGF.
| Effect modification by donor BMI
To examine whether the association between postdonation eGFR and 
| Sensitivity analysis and missing data
There were 12 589 (29.9%) donor-recipient pairs who were missing 6-month postdonation eGFR and thus were excluded from complete-case analysis of outcomes. To examine whether excluding these donors might have introduced a selection bias into our study, we used multiple imputation by chained equations to impute missing postdonation eGFR and repeated the analyses described above with the complete population. Our inferences remained the same; therefore we limited our primary analyses to cases that had complete data available (n = 29 464). Of the 29 464 subjects, only 344 (1.2%)
were missing donor BMI, and these were handled by complete-case analysis. There were no missing data for any other variable used in analysis.
| Statistical analysis
For descriptive purposes, postdonation eGFR above or below 60 mL/min per 1.73m 2 was selected for its clinical relevance. For
Kaplan-Meier curves of cumulative incidence of graft loss, we used quartiles of postdonation eGFR to demonstrate trends. For regression analysis, postdonation eGFR was examined as a continuous variable scaled per 10 mL/min. Fractional polynomial regression models were compared to models that included eGFR as a scaled linear variable; for both ACGF and DCGF, the models with eGFR as a linear variable had the better fit by AIC. Confidence intervals are reported as per the method of Louis and Zeger. 19 All analyses were performed using Stata 14.2/SE for Windows (College Station, TX).
| RE SULTS
| Study population: Living donors
Among 29 464 LDKT recipients, 1781 (6.0%) had a donor with 6-month postdonation eGFR <45 mL/min, 10 152 (34.5%) with eGFR 45-60 mL/min, 10 563 (35.8%) with eGFR 60-75 mL/min, 4913 (16.7%) with eGFR 75-90 mL/min, and 2055 (7.0%) with eGFR≥90 mL/min. Donors with postdonation eGFR<60 mL/min were older (median 51 years vs 38 years, P < .001), had higher BMI (median 27.0 vs 26.4, P < .001), were more likely to be male (38.6% vs 34.8%, P < .001) and Caucasian (86.1% vs 69.2%, P < .001), had lower predonation eGFR (median 86 vs 106 mL/min, P < .001), were less likely to be a first-degree relative (36.0% vs 42.6%), and were more likely to be a spouse or partner (16.8% vs 12.9%, P < .001) compared to those with higher postdonation eGFR (Table 1) . There was only a moderate correlation between 6-month postdonation eGFR and predonation eGFR (ρ = .65).
TA B L E 1 Characteristics of living kidney donor recipients and donors by 6-month postdonation estimated glomerular filtration rate (eGFR) <60 mL/min (n = 11 933) ≥60 mL/min (n = 17 531) P-value 
| Study population: LDKT recipients
LDKT recipients from donors with postdonation eGFR < 60 mL/min were older (median 53 years vs 48 years), more likely to be Caucasian (82.1% vs 66.9%, P < .001), and spent less time on dialysis (median 0.5 vs 0.6 years, P < .001) compared to LDKT recipients from donors with higher postdonation eGFR. Early posttransplant, LDKT recipients from donors with postdonation eGFR <60 mL/min had lower eGFR at hospital discharge following transplantation (median 51 vs 59 mL/min, P < .001) and higher prevalence of delayed graft function (3.6% vs 3.1%, P = .03) compared to LDKT recipients from donors with higher postdonation eGFR ( Table 1 ).
| All-cause graft failure
There were 2865 all-cause graft failures during 105 980. Table 2 ).
| Death-censored graft failure
There were 1536 death-censored graft failures during 105 980. Table 2 ).
| Effect modification by donor BMI
There was no modification of the association between postdonation eGFR and ACGF by donor BMI (P = .09) (Table 3) . However, the asso- Table 3 ).
| D ISCUSS I ON
In this national study of recipients of living donor kidney transplants, we found that, on average, recipients had a 5% higher risk of death-censored graft loss for every 10 mL/min decrement in their donors' postdonation eGFR. The association of graft loss and postdonation eGFR varied by donor BMI: LDKT recipients from donors with BMI 20 and 25 had 10% higher risk and 7% higher risk of DCGF for every 10 mL/ min decrement in postdonation eGFR, whereas recipients from obese donors had no association between DCGF and postdonation eGFR.
Our findings identify postdonation eGFR as a novel but intuitive risk factor for graft loss, and reaffirm that older donor age and higher donor BMI are risk factors for graft loss. relationship; that is, donors whose remaining kidney has less physiologic reserve are also donating a kidney that has less physiologic reserve to their recipient.
Of interest, we found that as donor BMI increased, there was less association between donor postnephrectomy eGFR and recipient death-censored graft loss. One explanation for this is that obese donors are more likely to have obesity-related glomerulomegaly, 16 and might already have some degree of hyperfiltration at the time of donation. Furthermore, obese donors are at higher risk of ESRD postdonation. 20 Our finding that higher donor BMI was associated with greater long-term risk of all-cause graft failure reaffirms findings from Massie et al. 21 A potential explanation for the conflicting findings regarding postdonation eGFR and graft loss from obese donors is that transplant providers are selecting obese donors who are otherwise quite healthy in other facets of evaluation. Therefore, some obese donors may be healthier than nonobese donors, despite being overweight.
Although we did adjust for multiple donor characteristics and comorbidities, it is possible that there is an unmeasured confounding that is related to this finding that we are unable to capture.
We echo others' recommendation that otherwise healthy donors should receive personalized counseling regarding their risk, which should include discussion of their individual risk factors including BMI. 20, 22, 23 Our findings should be considered in the context of several limitations. First, like all studies using national registry data, we are limited by missing data. Given the ongoing implementation of standard donor follow-up reporting, 29.9% of transplant recipients in this study were missing 6-month postdonation eGFR, consistent with national reports. 24 To address any potential bias related to this missingness, we performed both a complete-case analysis and a multiple imputation sensitivity analysis and found no difference in inferences. Our results support the concept that a donor's remaining kidney and donated kidney are associated, but we cannot conclude causative relationships with a registrybased study.
The identification of donor postdonation eGFR as a novel predictor for recipient graft loss strengthens our understanding of physi- 
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